Introduction
============

Dopaminergic signaling in the brain serves a critical role in cognitive functions ([@B33]; [@B36], [@B37]; [@B9]). This is especially evident in higher order executive functions modulated by the prefrontal cortex (PFC) such as attentional control, working memory, cognitive flexibility, and decision-making ([@B41]; [@B13]; [@B35]). In particular, consistent evidence indicates that the mesocortical dopaminergic system modulates these different cognitive processes by distinct receptor mechanisms. Specifically, activity of the D~1~-like (D~1~ and D~5~) receptor family has a strong impact on the regulation of working memory, attention, and recency memory across multiple species ([@B44]; [@B30]; [@B1]; [@B23]; [@B25]). In contrast, both D~1~-like and D~2~-like (D~2~, D~3~, D~4~) receptor families seem to be implicated in mediating the ability to shift between attentional sets (i.e., cognitive flexibility) ([@B14]). Unfortunately, currently available D~1~-like agonists and antagonists do not have significant selectivity for either the D~1~ or the D~5~ receptors ([@B32]). Moreover, in the cortex there is significant overlap between D~1~ and D~5~ receptor localization, and the D~1~ receptor is much more prevalent compared to the D~5~ receptor ([@B45]; [@B20]), further impeding the investigation of the selective role of D~5~ receptors in cortex-dependent cognitive functions.

The generation of D~1~ and D~5~ genetically modified mice has helped elucidate critical functions of the two receptors in multiple physiological processes ([@B46]; [@B26]; [@B28]; [@B15]; [@B18]). In particular, D~1~ receptor null mutants have deficits in higher order cognitive functions such as working memory ([@B10]; [@B50]; [@B16]; [@B49]). In contrast, there have been fewer studies on the behavioral effects of selective disruption of the D~5~ receptor. An early study of D~5~ knockout mice indicated that the behavioral consequences of the mutation were minimal. These mice showed no alterations in general health, sensory abilities, neurological reflexes, locomotor activity and coordination, prepulse inhibition, anxiety-like states measured with the elevated plus maze and light-dark box ([@B16]). In cognitive function, D~5~ knockout mice were first reported to have no alterations in performing the hippocampal-dependent Morris water maze or fear conditioning ([@B16]). However, a more recent study using mice with the same mutation found significant deficits in object recognition memory, object location memory, Morris water maze performance, and reduced locomotor activity ([@B29]). The discrepancies between these two studies may be due to differences in the experimental procedures or the different genetic backgrounds used ([@B16]: F2 129/SvJ1 X C57BL/6J; [@B29]: C57BL/6J). Additionally, there is still no information on how D~5~ receptor disruption affects PFC-dependent cognitive function such as spatial working memory and recency memory. The goal of the present study was to investigate the potential involvement of the D~5~ receptor in working memory function using a well-validated discrete paired-trial variable-delay non-match to place T-maze task ([@B36], [@B37]) and a temporal order object recognition task ([@B25]; [@B38]). Both tasks have been shown to rely on medial PFC functioning ([@B19]; [@B2]) and are sensitive to dopaminergic modulation ([@B17]; [@B37]; [@B25]).

We show that partial reduction ($D_{5}^{+/-}$) as well as the complete absence ($D_{5}^{-/-}$) of D~5~ receptors produces working memory and recency memory deficits suggesting a previously undetected direct role for D~5~ receptors in PFC-dependent higher order cognitive functions. Finally, we unraveled subtle, but selective alterations in molecular biomarkers within the mPFC of D~5~ knockout mice. These initial data identify a previously unknown role for the dopamine D~5~ receptor in cognition and related PFC functioning.

Materials and Methods {#s1}
=====================

Mice
----

The $D_{5}^{-/-}$ and their $D_{5}^{+/+}$ and $D_{5}^{+/-}$ littermates were produced as previously described ([@B16]). The mice from this mutant line were backcrossed with C57BL/6 mice for 10 generations before testing. We utilized a heterozygous breeding scheme in order to produce mixed litters with all three genotypes. Mouse genotypes were confirmed by PCR. Mice were weaned at P28 and group housed except in the T-maze experiments where mice were single housed starting 1 week before testing. Mice used for testing were male and between P63 and P126 days of age. All procedures were approved by the National Institute of Mental Health Animal Care and Use Committee and followed the National Institutes of Health *Using Animals in Intramural Research* Handbook.

Discrete Paired-Trial Variable-Delay T-Maze Task
------------------------------------------------

The procedure for this T-maze task was similar to one previously used in our laboratory ([@B36]). Mice were habituated to single housing for 1 week and were then food restricted to a level of 85% of their free-feeding weight. The mice were given 8 days for their weight to stabilize and received access to 10 reward pellets (5TUL 14 mg pellets; TestDiet, Richmond, IN, United States) during the last 3 days of this period. Following habituation to single housing and stabilization of body weight, mice were habituated to the T-maze apparatus over the course of two sessions. The T-maze apparatus was made of clear acrylic \[dimensions of arms (length × width × height): 40 × 10.2 × 17.5 cm\]. A recessed food cup was located at the end of each arm. During habituation sessions mice were allowed to retrieve reward pellets from the food cups. At the beginning of the session, each cup was baited with two reward pellets. The cups were re-baited continuously. Mice were allowed to retrieve 16 reward pellets during Session 1 and 20 reward pellets during Session 2. Each session automatically ended after 10 min if the mouse did not retrieve the maximum number of reward pellets. On the day following habituation, mice were given one session of 10 forced-alternation runs. For this session, one goal arm was blocked and the mouse had 2 min to consume the reward pellet located in the open arm. After an inter-trial interval of at least 15 min, the mouse was returned to the maze for another forced run with the open/closed arms switched. Training for the discrete paired-trial delayed alternation task began on the following day. Training consisted of 10 paired trials each day. A paired trial consisted of a forced run where one arm was blocked and the other arm was baited with a single reward pellet. The mouse was given 4 min to consume the pellet. Following consumption, the mouse was returned to the home cage for a 4-s intratrial delay. After the intratrial delay, the mouse was returned to the maze with access to both arms. The arm blocked on the forced run was now baited with two reward pellets. Again, the mouse was given 4 min to consume the reward pellets. After an inter-trial interval of at least 15 min, mice were returned for another trial. If the mouse entered the unbaited arm, this was recorded as an error and the mouse was removed from the maze. The normal inter-trial interval followed incorrect trials as well. Each testing session utilized a pseudo-randomly chosen pattern of 10 forced runs. Each day, the same pattern was used for each mouse. Mice were trained using these parameters for 20 days or until they reached 80% accuracy for 3 consecutive days. Mice that failed to reach 80% accuracy for 3 consecutive days within the 20-day training period were excluded from the study. Mice were then tested using variable intratrial intervals (4, 30, 60, and 240 s) and a 20-s inter-trial interval. Mice were given four trials of each inter-trial interval on 4 consecutive days.

Open Field Locomotor Activity
-----------------------------

The experimental apparatus consisted of a novel Plexiglas open field arena (42 × 42 × 30 cm) under red light illumination (5 ± 2 lux). Each mouse was allowed to freely explore the open field alone for 60 min. Horizontal locomotor activity was recorded using infrared photobeam sensors and the VersaMax Open Field Activity Monitoring system (AccuScan Instruments, Inc., Columbus, OH, United States).

Temporal Order Object Recognition Task
--------------------------------------

Temporal order object recognition testing was conducted as previously described ([@B25]). The apparatus and lighting conditions were identical to those used for the open field locomotor activity test. On day 1, mice were allowed to freely explore the open field for 60 min. Day 2 consisted of three 5-min sessions. During the first session, mice were allowed to explore two identical objects within the open field arena. The objects were either rectangular boxes (3 × 3 × 6 cm) or Erlenmeyer flasks (4 × 6 cm). The objects could either be white or black. During the second session, 1 h after the first session, mice were allowed to explore two objects of a different shape and color with respect to the objects from the first session. During the third session, 3 h after the second session, mice were allowed to explore one copy of each of the objects presented during the first and second sessions. The sessions were videotaped and scored offline by a reviewer blind to genotype. Mice were considered to be exploring an object when they faced the object and were ≤2 cm from the object. Discrimination between the objects in the third session was calculated using a discrimination index that accounts for individual differences in total exploration time. The index was calculated as the difference between the time spent exploring the object from the first session and the object from the second session divided by the total exploration time. Any mice that did not explore objects for more than 4 s during all of the sessions were excluded from the final analysis. One $D_{5}^{+/+}$, one $D_{5}^{+/-}$, and four $D_{5}^{-/-}$ mice were excluded because of low total exploration.

Immunoblotting
--------------

Frontal cortex tissue was obtained from naive $D_{5}^{+/+}$, $D_{5}^{+/-}$, and $D_{5}^{-/-}$ mice. Briefly, mice were killed by decapitation and the brain was removed and placed on a glass tray on ice. The olfactory bulbs were removed and the brain was cut along the midline. The frontal cortex (anterior to the corpus callosum) was removed and flash frozen on dry ice. The tissue was then stored at -80°C until processing. The tissue was then homogenized and sonicated in T-Per (Thermo Scientific, Rockford, IL, United States) lysis buffer. The protein concentration of the samples was determined by Bradford assay and all samples were diluted to a final concentration of 2 μg/μl. The samples were then combined with NuPage^®^ LDS Sample Buffer (ratio of 3:1 sample:LDS buffer). The protein was then denatured by heating at 95°C for 5 min. Samples were then run on pre-cast 4--12% Bis-Tris gels. After transfer to PVDF membranes, blots were blocked with 5% milk in TTBS for 1 h at room temperature. We probed the blots with the primary antibodies at 4°C overnight (**Table [1](#T1){ref-type="table"}**). Following three 10-min washes in TTBS, blots were probed with the goat anti-rabbit, goat anti-mouse (1:10,000 dilution; Chemicon, Temecula, CA, United States), or donkey anti-goat (1:1000; Santa Cruz Biotechnology, Dallas, TX, United States) secondary antibodies at room temperature for 1 h. Blots were developed in ECL-Plus (GE Healthcare, Piscataway, NJ, United States) and exposed to Kodak Bio-Max film. Films were digitized using a scanner, and the resulting images were analyzed using NIH Image gel plotting macros.

###### 

Primary antibodies.

  Antigen         Type (clone)       Dilution   Product number   Manufacturer
  --------------- ------------------ ---------- ---------------- ---------------------------
  pAkt (Thr308)   RbM (C31E5E)       1:1000     2965             Cell Signaling Technology
  pAkt (Ser473)   RbP                1:1000     9271             Cell Signaling Technology
  tAkt            MM (40D4)          1:2000     2920             Cell Signaling Technology
  Camkkbeta       GP                 1:1000     sc-9629          Santa Cruz Biotechnology
  Camk2           MM (G-1)           1:5000     sc-5306          Santa Cruz Biotechnology
  Camk4           GP                 1:200      sc-1541          Santa Cruz Biotechnology
  Drd2            MM (B-10)          1:1000     sc-5303          Santa Cruz Biotechnology
  Comt            MM (4/COMT)        1:10,000   611970           BD Biosciences
  pTH Ser40       RbP                1:800      AB5935           Millipore
  TH              RbP                1:2000     AB 152           Millipore
  GAPDH           MM (mAbcam 9484)   1:10,000   ab9484           Abcam
  Actin           RbP                1:5000     A2066            Sigma--Aldrich

RbM, rabbit monoclonal; RbP, rabbit polyclonal; MM, mouse monoclonal; GP, goat polyclonal.

Statistical Analysis
--------------------

The habituation and training phases of the T-maze task were analyzed using one-way ANOVAs with *post hoc* Bonferroni's tests. The variable delay portion was analyzed by a two-way ANOVA with genotype as the between-subjects factor and retention interval as the within-subjects factor and *post hoc* analyses utilized Bonferroni's tests at each of the retention intervals. Data from the temporal order object recognition task were analyzed using a one-way ANOVA with *post hoc* Bonferroni's tests. Protein quantification data for each mouse was first normalized to GAPDH levels (actin for TH protein levels) and then normalized to the mean $D_{5}^{+/+}$ value for each protein. Group means were then compared using one-way ANOVAs with *post hoc* Bonferroni's tests. All data are shown as the mean ± SEM.

Results
=======

D~5~ Genetic Disruption Did Not Alter Locomotor Functioning or Approach Responses to Food Reward
------------------------------------------------------------------------------------------------

To identify any potential confounding effects of D~5~ receptor disruption, we measured open field locomotor activity and approach responses to food reward in the T-maze apparatus. There were no D~5~ genotype differences in total locomotor activity (*F*~(2,30)~ = 0.06, *p* = 0.9420; **Figure [1A](#F1){ref-type="fig"}**) or any genotype × time interactions during any of the 5-min time bins within the 60-min test (*F*~(22,330)~ = 0.63, *p* = 0.9000; **Figure [1B](#F1){ref-type="fig"}**). As expected there was a significant decrease in activity over time for all groups (*F*~(11,330)~ = 35.68, *p* \< 0.0001; **Figure [1B](#F1){ref-type="fig"}**).

![Locomotor activity is normal in $D_{5}^{+/-}$ and $D_{5}^{-/-}$ mice. No difference between genotypes in either **(A)** total locomotor activity or **(B)** individual 5-min time bins. *n* = 6 in the $D_{5}^{+/+}$ group, 16 in the $D_{5}^{+/-}$ group, and 11 in the $D_{5}^{-/-}$ group.](fphar-08-00666-g001){#F1}

The first phase (two sessions) of the T-maze task is designed to habituate the mice to the testing apparatus and retrieval response required for completion of the task. All groups showed a significant decrease in latency to consume the first pellet from Day 1 to Day 2 (*F*~(1,30)~ = 41.71, *p* \< 0.0001; **Figure [2A](#F2){ref-type="fig"}**). Additionally, there were no differences in the raw latency values between the genotypes on either Day 1 or Day 2 (*F*~(2,30)~ = 1.20, *p* = 0.31). These data support the notion of a negligible impact of D~5~ on measures of locomotion and motivation.

![$D_{5}^{+/-}$ and $D_{5}^{-/-}$ mice display spatial working memory deficits. **(A)** During habituation, there are no genotype differences in latency to consume the first pellet. **(B)** All mice learn the non-match to sample rule in the same number of days. **(C)** $D_{5}^{-/-}$ mice had significantly lower accuracy compared to $D_{5}^{+/-}$ mice, but were no different from $D_{5}^{+/+}$ mice on the last 3 days of training. **(D)** During testing when the inter-trial interval was decreased to 20 s, $D_{5}^{-/-}$ mice showed decreased performance at the 4 and 30-s retention intervals compared to $D_{5}^{+/+}$ mice. Additionally, $D_{5}^{+/-}$ mice demonstrated impaired performance at the 30-s retention interval. *n* = 8 in the $D_{5}^{+/+}$ group, 15 in the $D_{5}^{+/-}$ group, and 9 in the $D_{5}^{-/-}$ group. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01 ($D_{5}^{-/-}$ compared to $D_{5}^{+/+}$) and ^\#^*p* \< 0.05 ($D_{5}^{+/-}$ compared to $D_{5}^{+/+}$).](fphar-08-00666-g002){#F2}

D~5~ Knockout Mice Learn the Non-match to Sample Rule at the Same Rate As $D_{5}^{+/+}$ Mice
--------------------------------------------------------------------------------------------

The next stage of the T-maze task consisted of training required for the mice to learn the non-match to sample rule. There were no significant differences in the number of sessions required to reach the criterion of three consecutive sessions above 80% accuracy (*F*~(2,29)~ = 0.70, *p* = 0.50; **Figure [2B](#F2){ref-type="fig"}**). However, there was a significant difference in accuracy during those last three training sessions (*F*~(2,29)~ = 3.63, *p* = 0.04; **Figure [2C](#F2){ref-type="fig"}**). The genotype effect on accuracy was driven by a slight, but significant, difference between $D_{5}^{+/-}$ and $D_{5}^{-/-}$ (*p* = 0.04). The difference between $D_{5}^{+/+}$ and $D_{5}^{-/-}$ was not significant (*p* = 0.22). These data indicate a marginal role of the D~5~ receptor in the ability to acquire working memory rules.

D~5~ Knockout Mice Have Working Memory Deficits Compared to $D_{5}^{+/+}$ When Tested in the Variable Retention Version of the Task
-----------------------------------------------------------------------------------------------------------------------------------

Following successful completion of the training phase, mice were tested in the variable retention delay portion of the task. In addition to the variable retention delays, the inter-trial delay was set at 20 s ([@B1]). Accuracy decreased as the retention interval increased across all genotypes (*F*~(2,29)~ = 11.00, *p* \< 0.0001). There was also a significant main effect of D~5~ genotype on performance (*F*~(2,29)~ = 4.91, *p* = 0.01). $D_{5}^{-/-}$ mice showed significantly impaired performance compared to $D_{5}^{+/+}$ on trials with either 4- or 30-s retention intervals (*p* = 0.004 and 0.001, respectively; **Figure [2D](#F2){ref-type="fig"}**). $D_{5}^{+/-}$ mice had impaired performance at the 30-s interval compared to $D_{5}^{+/+}$ mice (*p* = 0.033; **Figure [2D](#F2){ref-type="fig"}**). There were no significant differences between the genotypes on either the 60- or 240-s retention intervals due to a decrease in the choice accuracy of the $D_{5}^{+/+}$ mice. Interestingly, the $D_{5}^{+/-}$ mice had an intermediate phenotype suggesting that there is a gene dose effect of D~5~ dopamine receptor expression. These findings highlight a clear and previously undetected role of D~5~ receptors in working memory abilities.

$D_{5}^{+/-}$ Mice Have Recency Memory Deficits
-----------------------------------------------

Performance in a temporal order object recognition task, like the non-match to sample T-maze task, has been shown to depend on intact PFC function ([@B2]). There were no differences in total exploration between the three genotypes (*F*~(2,31)~ = 0.12, *p* = 0.89; **Figure [3A](#F3){ref-type="fig"}**), but there was a significant difference in the discrimination index (*F*~(2,31)~ = 3.33, *p* = 0.049; **Figure [3B](#F3){ref-type="fig"}**). *Post hoc* analysis indicated that the $D_{5}^{+/-}$ group had a significantly lower discrimination index compared to the $D_{5}^{+/+}$ group (*p* = 0.046), but only a tendency was evident for $D_{5}^{-/-}$ mice. Thus, there might be an U-shaped gene-dose effect on temporal order object recognition as the $D_{5}^{-/-}$ group's discrimination index was not different from the $D_{5}^{+/+}$ group's index (*p =* 0.52). One sample *t*-tests indicated that both the $D_{5}^{+/+}$ (*t*~(7)~ = 3.28, *p* = 0.01) and $D_{5}^{-/-}$ (*t*~(10)~ = 2.50, *p* = 0.03) groups showed significant recency memory while the $D_{5}^{+/-}$ (*t*~(14)~ = 0.44, *p* = 0.67) group did not.

![$D_{5}^{+/-}$ mice have impaired temporal order memory. **(A)** The differences in the recognition index were not confounded by any differences in total exploration time during the test phase. **(B)** Unlike $D_{5}^{+/+}$ and $D_{5}^{-/-}$, $D_{5}^{+/-}$ mice have no preference for the object presented during sample phase 1, indicating deficits in temporal order memory. *n* = 8 in the $D_{5}^{+/+}$ group, 15 in the $D_{5}^{+/-}$ group, and 11 in the $D_{5}^{-/-}$ group. ^∗^*p* \< 0.05 compared to $D_{5}^{+/+}$ and ^\#^*p* \< 0.05 compared to hypothetical zero.](fphar-08-00666-g003){#F3}

D~5~ Knockout Mice Show Selective Gene-Dose Effect on Akt Ser473 Phosphorylation in the PFC
-------------------------------------------------------------------------------------------

The working memory and temporal order recognition deficits exhibited by D~5~ mutant mice are similar to those our group has observed in other mouse genetic models of dopamine-related cognitive dysfunction ([@B36], [@B37]). Moreover, performance in the discrete paired-trial variable-delay T-maze and temporal order object recognition tasks has been shown to be modulated by alterations in PFC function ([@B19]; [@B2]). Thus, we next investigated whether D~5~ knockout mice might have working memory- and dopamine-related molecular alterations within the mPFC ([@B36], [@B35]; [@B47]; [@B11]; [@B25]).

We measured the relative amounts of multiple proteins in the frontal cortex across all three genotypes. These data are presented in **Figure [4](#F4){ref-type="fig"}**. Akt is a key intracellular regulatory protein involved in dopaminergic signaling and implicated in psychiatric disorders ([@B12]; [@B4]). There was no significant difference in pAkt Thr308 (*F*~(2,22)~ = 0.46, *p* = 0.63; **Figures [4A,B](#F4){ref-type="fig"}**) or total Akt (*F*~(2,22)~ = 0.46, *p* = 0.63). However, there was a significant genotype effect on pAkt Ser473 protein levels (*F*~(2,22)~ = 4.90, *p* = 0.02) with $D_{5}^{-/-}$ mice exhibiting increased phosphorylation compared to $D_{5}^{+/+}$ mice (*p* = 0.02). Despite seeing large changes in CAMKKβ protein levels in other genetic mouse models with working memory deficits ([@B36], [@B37]), there were no changes in the CAMKKβ 66 kDa (*F*~(2,22)~ = 0.03, *p* = 0.97) and a small, but not statistically significant, decrease in $D_{5}^{-/-}$ mice compared to $D_{5}^{+/+}$ on the 64 kDa (*F*~(2,22)~ = 2.315, *p* = 0.12) isoform. Protein levels of another Ca^2+^-dependent kinase CAMKII were not significantly different between the genotypes (*F*~(2,22)~ = 0.07, *p* = 0.94). Also, protein levels of the CAMKKβ substrate CAMKIV were unaffected by the D~5~ genotype (*F*~(2,22)~ = 0.31, *p* = 0.73). Finally, we measured levels of dopamine-associated proteins and found no significant differences in the D~2~ receptor (*F*~(2,22)~ = 1.19, *p* = 0.32), membrane-bound catechol-*O*-methyltransferase (COMT) (*F*~(2,22)~ = 0.65, *p* = 0.53), soluble COMT (*F*~(2,22)~ = 1.79, *p* = 0.19), phosphorylated (Ser40) tyrosine hydroxylase (TH) (*F*~(2,13)~ = 0.01, *p* \< 0.99), or TH total protein levels (*F*~(2,13)~ = 1.04, *p* \< 0.38; **Figures [4A,B](#F4){ref-type="fig"}**). Overall, these findings indicate a selective impact on PFC Akt activation by D~5~ receptor while sparing other dopamine-related biomarkers.

![Protein levels of potential molecular substrates in prefrontal cortex. **(A)** Representative blots for each genotype. *n* = 6 in the $D_{5}^{+/+}$ group, 13 in the $D_{5}^{+/-}$ group, and 6 in the $D_{5}^{-/-}$ group for all Western blots except for CaMKKbeta ($D_{5}^{+/+}$ group = 12, $D_{5}^{+/-}$ group = 19, and $D_{5}^{-/-}$ group = 11), TH, pTH Ser40, and actin ($D_{5}^{+/+}$ group = 6, $D_{5}^{+/-}$ group = 6, and $D_{5}^{-/-}$ group = 4). **(B)** Protein levels in $D_{5}^{+/-}$ and $D_{5}^{-/-}$ mice compared to $D_{5}^{+/+}$ mice. Data are normalized to the group mean for the $D_{5}^{+/+}$ group within each protein. The dashed line represents the $D_{5}^{+/+}$ mean (100%). ^∗^*p* \< 0.05 compared to $D_{5}^{+/+}$.](fphar-08-00666-g004){#F4}

Discussion
==========

In this study, we show that disruption of the dopamine D~5~ receptor results in impaired spatial working memory and temporal order memory function. These findings unravel a previously unidentified selective involvement of the D~5~ receptor as a critical modulator of higher order cognitive functions associated with the PFC.

The lack of pharmacological agents with selectivity for either the D~1~ or D~5~ receptor has made it difficult to identify the specific contributions of either receptor to central nervous system function and behavior ([@B32]). Previous research with total $D_{5}^{-/-}$ mice and conditional constructs indicated that the D~5~ receptor, in contrast to the D~1~ receptor, plays a modest role in dopamine-mediated behaviors ([@B16]; [@B18]; [@B43]). However, recent studies utilizing $D_{5}^{-/-}$ mice suggest a role in fear memory consolidation through modulation of phospholipase C signaling ([@B34]) and a role in regulating BDNF and Akt function in the PFC ([@B40]). A recent study using the same line of D~5~ mutant mice as our current study also identified deficits in spatial and recognition memory in the knockout mice ([@B29]). Those mice also exhibited reduced locomotor activity, reduced object exploration, and increased anxiety-related states (i.e., increased latency to explore objects), not seen by either [@B16] or us, that may have influenced their cognitive performance. The differences in locomotor activity and object exploration between our study and the report of Morago-Amaro and colleagues may be due to differences in experimental procedures or genetic background. Nonetheless, loss of the D~5~ receptor appears to significantly alter behavior including cognitive function. The spatial working memory deficit we describe is similar to other genetic mouse models characterized by altered dopaminergic function in the PFC ([@B36], [@B37]). These findings indicate that dopaminergic signaling through the D~5~ receptor may serve a previously underappreciated role in behavior. Our current work is the first report indicating the involvement of the D~5~ receptor in spatial working memory function measured with a delayed non-match to place T-maze task.

Previous studies using D~1/5~ agonists and antagonists have implicated D~1~-like receptors in the regulation of working memory ([@B1]; [@B27]). Additionally, the D~5~ receptor is widely expressed in the cerebral cortex and hippocampus, regions critically involved in spatial working memory function ([@B21]; [@B24]; [@B8]; [@B20]), suggesting there may be a specific role for the D~5~ receptor. Interestingly, there appears to be some redundancy in D~1~-like receptor modulation of working memory. Indeed, D~1~ receptor knockout mice, like D~5~ receptor knockout mice, show deficits in working memory function and abnormal regulation of BDNF in the PFC ([@B49]). Like spatial working memory, temporal order recognition memory requires intact signaling between the PFC and hippocampus ([@B2]; [@B3]). Here we report a potential U-shaped relationship between the degree of D~5~ receptor insufficiency and performance in the temporal order recognition task in contrast to the apparent linear gene-dose relationship seen in spatial working memory. Although the underlying cause of the discrepancy between relative performance in the temporal order object recognition task and discrete paired-trial variable-delay T-maze is unknown, previous research has shown that the optimal dopaminergic tone is variable depending on the particular task with which the animal is currently engaged ([@B13]).

In the current experiments, we investigated the protein levels of CaM kinases because previous studies using mouse models of dopaminergic dysfunction suggested a role for this family of kinases in modulating working memory in this particular T-maze task ([@B37]). In particular, our previous studies linked an alteration of overall dopamine levels within the PFC ([@B36]) or altered D~2~ trafficking ([@B37]) with CaM kinases expression. In contrast, no major D~5~-dependent effect was evident in CaM levels, with the possible exception of the brain-specific CaMKKβ isoform. We did not observe any alterations in TH or dopamine D~2~ receptor protein levels. Moreover, previous research demonstrated no change in dopamine D~1~ receptor function following D~5~ inactivation ([@B15]). Thus, our findings combined with previous evidence that D~1~/D~5~ receptor pathways modulate PFC long-term potentiation and intrinsic excitability through the activation of CaMK pathways ([@B7]) suggest a possible selective role of D~1~ receptors in these processes.

The only significant change in our protein assays in the PFC resulting from the loss of the D~5~ receptor was an increase in pAkt (Ser473). This might be in agreement with previous pharmacological manipulation suggesting that the D~5~ receptor regulates phosphorylation of Akt in the PFC in mice ([@B40]). Akt activity has been linked to cell proliferation, growth, survival, and metabolism, and it has been implicated in sex differences and psychiatric disorders ([@B6]; [@B12]; [@B5]; [@B42]). In particular, Akt activity has been proposed as an intracellular key regulatory protein directly linked to the activity of D~2~ postsynaptic receptors ([@B4]). Here we add new evidence implicating D~5~ receptors in Akt-mediated signaling that will require further and more focused investigation.

The D~5~ receptor is uniquely located to play an important role in modulation of PFC function. Anatomical studies in nonhuman primates show that D~5~ receptors are positioned in extrasynaptic microdomains where they can interact with the 1,4,5-triphosphate receptor to mobilize calcium from intracellular stores ([@B39]). These microdomains are critical locations for the signaling mechanisms underlying dopaminergic volume transmission in the cortex. The current results point specifically to a critical role for the D~5~ receptor in PFC-dependent spatial working memory as well as recency memory. Further studies may serve to define the parameters of D~5~ dopamine receptor activity as it relates to other cognitive domains. However, given the relatively precise localization of D~5~ receptors, a therapeutic strategy selectively targeting them may improve cognitive function with potentially fewer side effects compared to drugs selectively targeting the D~1~ receptor. This would be relevant for many neurological and psychiatric disorders, such as schizophrenia, bipolar disorders, and others ([@B48]; [@B31]; [@B22]).

Conclusion
==========

$D_{5}^{+/-}$ and $D_{5}^{-/-}$ mice have spatial working memory deficits in a discrete paired-trial variable-delay T-maze task as well as recency memory deficits in a temporal order object recognition task. These data represent new evidence that the dopamine D~5~ receptor is directly involved in higher order cognitive functions.
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